Computational Anatomy in Surgery for Childhood Tumours and Malformations
Launched by IMAGINE INSTITUTE · Jan 17, 2024
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- To be included, patients must meet the following criteria:
- • Patient aged between 5 months and 17 years
- * Patient with a confirmed diagnosis of :
- • Abdomino-pelvic tumour
- • Pelvic malformation
- • Patient whose parents or legal guardians have read, accepted and signed the study consent form
- • Patients whose parents or legal guardians are beneficiaries of a social security scheme.
- To be included, control patients (patients other than those suffering from an abdomino-pelvic tumour or malformation) must meet the following criteria:
- • Patient aged between 5 months and 17 years inclusive.
- • A patient being followed in the visceral surgery department for a pathology other than tumour or malformation, and requiring MRI as part of his or her diagnosis, extension assessment or monitoring.
- • Patient whose parents or legal guardians have read, accepted and signed the study consent form.
- • Patient whose parents or guardians are beneficiaries of a social security scheme.
- Non inclusion criteria :
- • Patients
- • Patient with a contraindication to MRI: metallic ocular foreign body, pacemaker, mechanical cardiac valve, old vascular clips on cerebral aneurysm, etc.
- • Patient having participated in a therapeutic clinical trial involving a new molecule in the 30 days prior to inclusion.
- Controls :
- • Patient with a contraindication to MRI: ocular metallic foreign body, pacemaker, cardiac mechanical valve, old vascular clips on cerebral aneurysm, etc.
- • Patient having participated in a therapeutic clinical trial involving a new molecule in the 30 days prior to inclusion.
About Imagine Institute
The Imagine Institute is a leading research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. Committed to fostering collaboration among scientists, clinicians, and industry partners, the Institute focuses on pioneering research in genetic and rare diseases. With a state-of-the-art facility and a multidisciplinary team of experts, the Imagine Institute aims to translate groundbreaking discoveries into effective therapies, ensuring that cutting-edge treatments are accessible to those in need. Its commitment to excellence and patient-centric approach positions the Imagine Institute as a key player in the landscape of clinical research and healthcare innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Ile De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported